Patient Diversity And FDA's Office Of Minority Health And Health Equity

Source: Clinical Leader

Patient diversity remains a problem in clinical trials. Although FDA- approved medicines serve a diverse population of Americans, participation in clinical trials remains predominantly white and male. The FDA would like to address this problem, and one of its tools is the Office of Minority Health and Health Equity in the Office of the Commissioner at FDA.

In this webinar segment, RADM Richardae Araojo, associate commissioner for minority health and director of the Office of Minority Health and Health Equity, discusses the office and her role in it. She notes work the office is doing with CTTI and MRCT at Harvard. Araojo also notes many of the educational materials her office has available to assist with recruiting minority patients into clinical trials.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader